Patent applications published 23 March 2011
Selected patent applications from the weekly European Patents Bulletin
- Kappa opioid receptor ligands
Research Triangle Institute 2296469*
- Compsns and methods for inhibiting gastric secretion
Vecta 2296470*
- Muscarinic agonists as cognitive enhancers
University of Toledo; The Board of Trustees of the University of Illinois 2296471*
- Compounds for rho kinase inhibition and for improving learning and memory
Amnestix 2296472*
- Novel substituted indoles
Merck Sharp & Dohme 2296474*
- Triazolopyridine JAK inhibitor compounds and methods
Genentech 2296475*
- Brown adipocyte progenitors in human skeletal muscle
Boss, Olivier; Giacobino, Jean-Paul 2296478*
- Palatability enhancers and methods for enhancing palatability
Nestec 2296481*
- Compsns for the treatment of lice
Sinclair Pharmaceuticals 2296623*
- New emulsions for producing medicinal products
Boehringer Ingelheim International 2296625*
- Azide modified proteins
Koninklijke Philips Electronics 2296626*
- Micelles for intracellular delivery of therapeutic agents
The University of Washington; Phaserx 2296627*
- Process for manufacturing flowable powder drug compsns
3M Innovative Properties 2296628*
- Biocompatible and biodegradable elastomeric polymers
Surmodics Pharmaceuticals 2296629*
- Delivery of nucleic acid complexes from particles
SurModics 2296630*
- Method for manufacturing medicinal compounds containing dabigatran
Boehringer Ingelheim International 2296631*
- Controlled release apoptosis modulating compsns and methods for the treatment of otic disorders
Otonomy; The Regents of the University of California 2296632*
- The use of solid carrier particles to improve the processability of a pharmaceutical agent
Gilead Sciences 2296633*
- Process for manufacture of a medicament with granulation and pan coating
Dexcel Pharma Technologies 2296634*
- Artificial oxygen carriers and use thereof
Universität Duisberg-Essen 2296635*
- Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
Consorzio per il Centro di Biomedicina Molecolare Scrl 2296636*
- Chitosan-containing protective compsn
Medtronic 2296637*
- Identification of a molecular signature for antipsychotics and serms
Vanda Pharmaceuticals 2296638*
- Emollient compsn for the preventative treatment of atopic dermatitis
Pierre Fabre Dermo-Cosmétique 2296639*
- Methods for preventing the development of retinopathy by the oral administration of NNR ligands
Targacept; Toler, Steve; Lippielli, Patrick; Cullison, Scott; Bencherif, Merouane 2296640*
- Diarul urea for treating heart failure
Bayer Schering Pharma Aktiengesellschaft 2296641*
- Compsns comprising amino acids, with pro-angiogenic activity
Professional dietetics 2296642*
- Nutritional compsn for improving the mammalian immune system
NV Nutricia 2296643*
- Combination compsns comprising antimcoytic agents and statins and the use thereof
Pannonpharma Gyógyszergyártó Kft 2296644*
- Combination antitumour therapy
Kereos 2296645*
- Novel treatments
Minster Research 2296646*
- PAI-1 expression and activity inhibitors for the treatment of ocular disorders
Alcon Research 2296647*
- Naphthylmethylimidizoles for the treatment of stress urinary incontinence
Allergan 2296648*
- Oxazolidiones for the treatment of inflammatory conditions of the gastrointestinal tract
Bayer Schering Pharma Aktiengesellshaft 2296649*
- Immunomodulation by IAP inhibitors
Novartis; Dana Farber Cancer Institute 229650*
- 5-hydroxylmethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
Actelion Pharmaceuticals 2296651*
- Topical regional neuro-affective therapy
Afgin Pharma 2296652*
- Compounds and methods for treating inflammatory and fibrotic disorders
Intermune 2296653*